Author: P Fishman, NB Coe, L White, S Park, B Ingraham, EB Larson
In this article, the authors conducted a systematic review of studies reporting the direct healthcare costs of treating older adults with diagnosed Alzheimer disease and related dementias (ADRD) within private Medicare managed care plans.
This article estimates out-of-pocket costs in the last year of life for individuals who required intensive care in the months prior to death and examine how these costs vary by insurance coverage.
Author: Moderator: Nora Super, Milken Institute. Speakers: Norma Coe, University of Pennsylvania; Linda Elam, Amerigroup District of Columbia, Inc.; Howard Fillit, Alzheimer’s Drug Discovery Foundation; George Vradenburg, UsAgainstAlzheimer’s
Dr. Coe spoke at the 2019 Milken Institute Global Conference on the price of dementia. Dr. Coe’s comments focused on the effect that Alzheimer’s disease and related dementias have on individuals and their families and how this then affects our economy.
Type: ADRD, Long-term care, Caregiving, Informal Care
Author: P Chatterjee, M Qi, NB Coe, RT Konetzka, RM Werner
Medicare pays for 100% of postacute care provided by skilled nursing facilities (SNFs) during the first 20 days within a benefit period. However, on the 21st day, most patients become responsible for a daily copayment of more than $150. This copayment may present a significant financial burden for some patients—particularly those with limited economic means—and motivate them to discharge from SNFs on the 20th day of care based on their financial resources rather than their recovery status. In this article, the researchers examine whether patterns of SNF discharge are associated with this
This article details the ways in which financial burden imposed by work-related injury/illness, and points out areas which are under-researched to focus policy efforts where improvement is most needed.
